Nxera Pharma Co Ltd (SOLTF)
8.052
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Nxera Pharma Debt to Equity Ratio: 0.9607 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.9607 |
| March 31, 2024 | 1.027 |
| December 31, 2023 | 1.035 |
| September 30, 2023 | 1.178 |
| June 30, 2023 | 0.4509 |
| March 31, 2023 | 0.483 |
| December 31, 2022 | 0.483 |
| September 30, 2022 | 0.4999 |
| June 30, 2022 | 0.4916 |
| March 31, 2022 | 0.4875 |
| December 31, 2021 | 0.4775 |
| September 30, 2021 | 0.5078 |
| June 30, 2021 | 0.2676 |
| March 31, 2021 | 0.27 |
| December 31, 2020 | 0.2823 |
| September 30, 2020 | 0.3053 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.1504 |
| June 30, 2019 | 0.1729 |
| March 31, 2019 | 0.1838 |
| December 31, 2018 | |
| September 30, 2018 | 0.1699 |
| June 30, 2018 | 0.1816 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.1877 |
| December 31, 2017 | 0.1955 |
| September 30, 2017 | 0.3421 |
| June 30, 2017 | 0.3721 |
| March 31, 2017 | 0.2434 |
| December 31, 2016 | 0.2427 |
| September 30, 2016 | 0.288 |
| June 30, 2016 | 0.2856 |
| March 31, 2016 | 0.3819 |
| December 31, 2015 | 0.3139 |
| September 30, 2015 | 0.4243 |
| June 30, 2015 | 1.235 |
| March 31, 2015 | 1.361 |
| December 31, 2014 | 0.001 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
1.178
Maximum
Sep 2023
0.4846
Average
0.483
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.7299 |
| PeptiDream Inc | 0.3561 |
| Healios KK | 1.863 |
| AnGes Inc | 0.00 |
| SanBio Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 972.39M |
| Total Liabilities (Quarterly) | 543.75M |
| Shareholders Equity (Quarterly) | 428.64M |
| Current Ratio | 4.105 |
| Net Debt Paydown Yield | 4.74% |